Carlsmed Medical (CARL) Long-Term Liabilities to Equity

Serving as the primary valuation tool, this Carlsmed Inc (CARL) price chart demonstrates the dynamics of a company creating personalized spinal implants. Its revenues are independent of market cycles or seasonality, and the indicator stands at 0.26. The application of additive technologies minimizes production defects, aligning with ESG standards. Stable management relies on a robust patent portfolio, ensuring steady interest from major funds.

This ratio is calculated as the proportion of liabilities with a maturity exceeding one year to equity, measuring the degree of financial leverage and the stability of the balance sheet structure. In the context of Carlsmed Inc. (CARL), analyzing the dynamics of long-term debt-to-equity on GURU.Markets allows for an assessment of the company's ability to finance the implementation of complex implants amidst the risks of non-payment by insurance companies.